About Shenzhen Xinlitai Pharmaceutical
Shenzhen Xinlitai Pharmaceutical was founded in 1998 and operates in the pharmaceuticals sector. Small molecule therapies are developed, with the lead candidate SAL-067 advancing in phase 2 trials for diabetes. Additional candidates are pursued in preclinical and phase 1 stages for cancers and cardiovascular conditions. Biologic therapeutics, medical devices, and gene therapies are also developed, alongside the manufacturing of generic products. Operations are based in Greenview, United States.
- Headquarter Greenview, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shenzhen Xinlitai Pharmaceutical
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Post-IPO - Shenzhen Xinlitai Pharmaceutical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shenzhen Xinlitai Pharmaceutical
Shenzhen Xinlitai Pharmaceutical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Carlyle Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shenzhen Xinlitai Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shenzhen Xinlitai Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shenzhen Xinlitai Pharmaceutical Comparisons
Competitors of Shenzhen Xinlitai Pharmaceutical
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shenzhen Xinlitai Pharmaceutical
Frequently Asked Questions about Shenzhen Xinlitai Pharmaceutical
When was Shenzhen Xinlitai Pharmaceutical founded?
Shenzhen Xinlitai Pharmaceutical was founded in 1998 and raised its 1st funding round 22 years after it was founded.
Where is Shenzhen Xinlitai Pharmaceutical located?
Shenzhen Xinlitai Pharmaceutical is headquartered in Greenview, United States. It is registered at Greenview, Illinois, United States.
What does Shenzhen Xinlitai Pharmaceutical do?
Shenzhen Xinlitai Pharmaceutical was founded in 1998 and operates in the pharmaceuticals sector. Small molecule therapies are developed, with the lead candidate SAL-067 advancing in phase 2 trials for diabetes. Additional candidates are pursued in preclinical and phase 1 stages for cancers and cardiovascular conditions. Biologic therapeutics, medical devices, and gene therapies are also developed, alongside the manufacturing of generic products. Operations are based in Greenview, United States.
Who are Shenzhen Xinlitai Pharmaceutical's investors?
Shenzhen Xinlitai Pharmaceutical has 1 investor. Key investors include The Carlyle Group.